Sponsored
by Precision for Medicine
How the Right Biospecimens Plan Can Boost Drug Development
Biospecimen quality is critical to the success of clinical research. Selecting the right supplier is…
10/12/2020 - 5 minutes
External Contributor
These are all the posts from our lovely external contributors. If you want to contribute too, drop us a line at contact-at-www.labiotech.eu
Everything You Need to Know About Biotech Business Models
What's my business model? Who do I partner with? How do I scale up? These…
14/10/2020 - 6 minutes
Sponsored
by GenScript
Antibodies: A Beacon of Hope During the Covid-19 Pandemic Dark Days?
Covid-19 has swept the globe, changing the way we view the world, probably forever. Nearly…
07/10/2020 - 5 minutes
The Complications Around Patenting Biotechnology
Many people around the world start their mornings with a glass of orange juice. What…
05/10/2020 - 7 minutes
The Funding Flow Between European and US Life Sciences
Funding is the lifeline of innovative ventures. In an increasingly uncertain environment, looking at the…
14/09/2020 - 11 minutes
Sponsored
by AiCuris
PREP-ing for Future Pandemics and AMR
As the Covid-19 pandemic rages, worries about rising antimicrobial resistance are increasing too. One company…
14/09/2020 - 6 minutes
Negotiating Early-Stage Biotech Valuation: VC vs Entrepreneur
There is usually a big disparity between investors and entrepreneurs regarding the valuation of an…
26/08/2020 - 7 minutes
Overcoming the Limitations of CRISPR Gene Editing with RNA Editing
A once forgotten technology, RNA editing has been gaining traction as a treatment for genetic…
17/08/2020 - 6 minutes
Meet 10 European Biotech Initiatives Increasing Wildlife Biodiversity
In the fight against shrinking biodiversity, biotechnology could be a lifesaver. These European biotech initiatives…
03/08/2020 - 6 minutes
UK Startup Bags €37M to Remove Cell Therapy Manufacturing Bottleneck
UK biotech startup Bit Bio has received €36.9M in Series A funding to boost the…
16/06/2020 - 3 minutes
AbbVie and Genmab Strike €3.4B Immuno-Oncology Megadeal
AbbVie and Genmab have announced a €3.4B collaboration deal that ranks as the second biggest…
11/06/2020 - 3 minutes
Bavarian Nordic’s Vaccine Shows Biodefense Potential in Phase I
With a successful phase I clinical trial, Danish biotech Bavarian Nordic has come a step…
09/06/2020 - 3 minutes
